G. Hatemi Et Al. , "Improvements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF)," Annual Meeting of the American-Academy-of-Dermatology (AAD) , vol.81, Washington, Kiribati, 2019
Hatemi, G. Et Al. 2019. Improvements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF). Annual Meeting of the American-Academy-of-Dermatology (AAD) , (Washington, Kiribati).
Hatemi, G., Mahr, A., Takeno, M., Kim, D., Melikoglu, M., Cheng, S., ... McCue, S.(2019). Improvements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF) . Annual Meeting of the American-Academy-of-Dermatology (AAD), Washington, Kiribati
Hatemi, Gülen Et Al. "Improvements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF)," Annual Meeting of the American-Academy-of-Dermatology (AAD), Washington, Kiribati, 2019
Hatemi, Gülen Et Al. "Improvements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF)." Annual Meeting of the American-Academy-of-Dermatology (AAD) , Washington, Kiribati, 2019
Hatemi, G. Et Al. (2019) . "Improvements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF)." Annual Meeting of the American-Academy-of-Dermatology (AAD) , Washington, Kiribati.
@conferencepaper{conferencepaper, author={Gülen HATEMİ Et Al. }, title={Improvements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF)}, congress name={Annual Meeting of the American-Academy-of-Dermatology (AAD)}, city={Washington}, country={Kiribati}, year={2019}}